The burgeoning popularity of tirzepatide , initially for diabetes , is creating significant attention within the United Kingdom , prompting a notable shift in peptide trends. Obtaining these medications remains a complex landscape, with National Health Service approval currently limited and independent providers offering treatment at a substantial